Related Experiment Video
Updated: Jun 23, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Glufosinate ammonium poisoning: A rare clinical presentation
Venkat Manolasya1, Praveena Prasanth1, Bayyareddy Venkata Rami Reddy1
1Department of Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India.
Abstract:
A 32-year-old male presented with a history of decreased urine output following an alleged history of deliberate self-harm by consuming glufosinate ammonium 13.5% w/w SL herbicide (Synkill®) two days earlier. General physical examination revealed pulse 86 beats/minute, blood pressure 140/90 mmHg, and respiratory rate 20/minute. Laboratory investigations revealed elevated serum creatinine (5.96 mg/dl), creatinine phosphokinase (340 i.u./L), and elevated serum hepatic transaminases. On day 6 of hospitalization, he developed right-sided lower motor neuron facial palsy and was started on oral prednisolone. The following day, the weakness progressed, and bilateral lower motor neuron facial palsy developed. During the next few days, a descending type of flaccid paralysis developed, including involvement of respiratory muscles, requiring assisted mechanical ventilatory support. Magnetic resonance imaging (MRI) of the brain showed a normal study. The electroneuromyography test showed prolonged latency with reduced amplitude and conduction velocity. The sensorium of the patient also worsened with a Glasgow Coma Scale (GCS) of E1VTM1 by day 11 of hospital stay. A computed tomography scan of the brain done after a fall in GCS showed no abnormality of the brain parenchyma. The blood and urine samples sent for toxicological analysis revealed the presence of glufosinate in urine alone. The patient was discharged against medical advice from the hospital. Our patients highlights a very rare manifestation of glufosinate ammonium herbicide poisoning.
Related Concept Videos
Hepatic Encephalopathy
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies
Pharmaceutical Poisoning: Potential Scenarios
Prevention of Further Absorption of Poison
Physical Properties of Amines